Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3307-3319

  Zoso, Alessia ^a   Mazza, Emilia M C ^b   Bicciato, Silvio ^b   Mandruzzato, Susanna ^c,d   Bronte, Vincenzo ^e   Serafini, Paolo ^a,f   Inverardi, Luca ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrocytes; Genomic analysis; IDO; Myeloid derived suppressor cells; Treg cells; Type 1 diabetes

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; RECOMBINANT PROTEIN;

ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; FEMALE; FETUS BLOOD; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEK293 CELL LINE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; REGULATORY T LYMPHOCYTE; SCID MOUSE; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEK293 CELLS; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, SCID; MYELOID CELLS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84916908891     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444522     Document Type: Article

References (46)

1. Montero, A. J., Diaz-Montero, C. M., Kyriakopoulos, C. E., Bronte, V. and Mandruzzato, S., Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J. Immunother. 2012. 35: 107-115.
2. Vollbrecht, T., Stirner, R., Tufman, A., Roider, J., Huber, R. M., Bogner, J. R., Lechner, A. et al., Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012. 26: F31-F37.
3. Fast, D. J., Shannon, B. J., Herriott, M. J., Kennedy, M. J., Rummage, J. A. and Leu, R. W., Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity. Infect Immun 1991. 59: 2987-2993.
4. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
5. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
6. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M. et al., Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010. 40: 22-35.
7. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S. and Bronte, V., Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010. 22: 238-244.
8. Youn, J. I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A. et al., Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 2013. 3: 211-220.
9. Serafini, P., Mgebroff, S., Noonan, K. and Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008. 68: 5439-5449.
10. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M. et al., Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 1123-1131.
11. Pan, P. Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M. et al., Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 2010. 70: 99-108.
12. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F. et al., A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008. 135: 234-243.
13. Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W. et al., Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 2013. 190: 3783-3797.
14. Zhang, H., Maric, I., Diprima, M. J., Khan, J., Orentas, R. J., Kaplan, R. N. and Mackall, C. L., Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013. 122: 1105-1113.
15. Cools, N., Ponsaerts, P., Van Tendeloo, V. F. and Berneman, Z. N., Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 2007. 82: 1365-1374.
16. Ezzelarab, M. and Thomson, A. W., Tolerogenic dendritic cells and their role in transplantation. Semin. Immunol. 2011. 23: 252-263.
17. Serafini, P., Borrello, I. and Bronte, V., Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 2006. 16: 53-65.
18. Youn, J. I. and Gabrilovich, D. I., The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 2010. 40: 2969-2975.
19. Gabrilovich, D. I., Ostrand-Rosenberg, S. and Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012. 12: 253-268.
20. Ochando, J. C. and Chen, S. H., Myeloid-derived suppressor cells in transplantation and cancer. Immunol. Res. 2012. 54: 275-285.
21. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S. et al., Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010. 32: 790-802.
22. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A. et al., IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 2009. 182: 6562-6568.
23. Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R. and Ochoa, A. C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009. 69: 1553-1560.
24. Solito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S. et al., A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011. 118: 2254-2265.
25. Young, M. R., Petruzzelli, G. J., Kolesiak, K., Achille, N., Lathers, D. M. and Gabrilovich, D. I., Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells. Hum. Immunol. 2001. 62: 332-341.
26. Van Hal, P. T., Hopstaken-Broos, J. P., Wijkhuijs, J. M., Te Velde, A. A., Figdor, C. G. and Hoogsteden, H. C., Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. J. Immunol. 1992. 149: 1395-1401.
27. Galligan, C. L. and Fish, E. N., The role of circulating fibrocytes in inflammation and autoimmunity. J. Leukoc. Biol. 2013. 93: 45-50.
28. Wang, J., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T. W. and Toes, R. E., Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007. 37: 129-138.
29. Weed, D. T., Walker, G., De La Fuente, A. C., Nazarian, R., Vella, J. L., Gomez-Fernandez, C. R. and Serafini, P., FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma. PLoS One 2013. 8: e71908.
30. Magg, T., Mannert, J., Ellwart, J. W., Schmid, I. and Albert, M. H., Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur. J. Immunol. 2012. 42: 1627-1638.
31. Adeegbe, D., Serafini, P., Bronte, V., Zoso, A., Ricordi, C. and Inverardi, L., In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice. Cell Transplant 2011. 20: 941-954.
32. Lechner, M. G., Liebertz, D. J. and Epstein, A. L., Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 2010. 185: 2273-2284.
33. Bellini, A. and Mattoli, S., The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 2007. 87: 858-870.
34. Serafini, P., Mgebroff, S., Noonan, K. and Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008. 68: 5439-5449.
35. Ko, H. J., Lee, J. M., Kim, Y. J., Kim, Y. S., Lee, K. A. and Kang, C. Y., Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine. J. Immunol. 2009. 182: 1818-1828.
36. Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E. and Gabrilovich, D. I., Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 2010. 184: 3106-3116.
37. Nagaraj, S., Nelson, A., Youn, J. I., Cheng, P., Quiceno, D. and Gabrilovich, D. I., Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 2012. 72: 928-938.
38. Liu, H., Liu, L., Liu, K., Bizargity, P., Hancock, W. W. and Visner, G. A., Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2, 3-dioxygenase-dependent immune suppression. J. Immunol. 2009. 183: 1022-1031.
39. Lob, S., Konigsrainer, A., Zieker, D., Brucher, B. L., Rammensee, H. G., Opelz, G. and Terness, P., IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol. Immunother. 2009. 58: 153-157.
40. Mougiakakos, D., Jitschin, R., von Bahr, L., Poschke, I., Gary, R., Sundberg, B., Gerbitz, A. et al., Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 2013. 27: 377-388.
41. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U. and Speed, T. P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003. 4: 249-264.
42. Dai, M., Wang, P., Boyd, A. D., Kostov, G., Athey, B., Jones, E. G., Bunney, W. E. et al., Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005. 33: e175.
43. Fallarino, F., Volpi, C., Fazio, F., Notartomaso, S., Vacca, C., Busceti, C., Bicciato, S. et al., Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat. Med. 2010. 16: 897-902.
44. Johnson, W. E., Li, C. and Rabinovic, A., Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007. 8: 118-127.
45. Tusher, V. G., Tibshirani, R. and Chu, G., Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001. 98: 5116-5121.
46. Britten, C. M., Janetzki, S., Butterfield, L. H., Ferrari, G., Gouttefangeas, C., Huber, C., Kalos, M. et al., T cell assays and MIATA: the essential minimum for maximum impact. Immunity 2012. 37: 1-2.